Your browser doesn't support javascript.
loading
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Clark, Amy S; Yau, Christina; Wolf, Denise M; Petricoin, Emanuel F; van 't Veer, Laura J; Yee, Douglas; Moulder, Stacy L; Wallace, Anne M; Chien, A Jo; Isaacs, Claudine; Boughey, Judy C; Albain, Kathy S; Kemmer, Kathleen; Haley, Barbara B; Han, Hyo S; Forero-Torres, Andres; Elias, Anthony; Lang, Julie E; Ellis, Erin D; Yung, Rachel; Tripathy, Debu; Nanda, Rita; Wulfkuhle, Julia D; Brown-Swigart, Lamorna; Gallagher, Rosa I; Helsten, Teresa; Roesch, Erin; Ewing, Cheryl A; Alvarado, Michael; Crane, Erin P; Buxton, Meredith; Clennell, Julia L; Paoloni, Melissa; Asare, Smita M; Wilson, Amy; Hirst, Gillian L; Singhrao, Ruby; Steeg, Katherine; Asare, Adam; Matthews, Jeffrey B; Berry, Scott; Sanil, Ashish; Melisko, Michelle; Perlmutter, Jane; Rugo, Hope S; Schwab, Richard B; Symmans, W Fraser; Hylton, Nola M; Berry, Donald A; Esserman, Laura J.
Afiliación
  • Clark AS; University of Pennsylvania, Philadelphia, PA, USA. Amy.Clark@pennmedicine.upenn.edu.
  • Yau C; University of California San Francisco, San Francisco, CA, USA.
  • Wolf DM; University of California San Francisco, San Francisco, CA, USA.
  • Petricoin EF; George Mason University, Fairfax, VA, USA.
  • van 't Veer LJ; University of California San Francisco, San Francisco, CA, USA.
  • Yee D; University of Minnesota, Minneapolis, MN, USA.
  • Moulder SL; MD Anderson Cancer Center, Houston, TX, USA.
  • Wallace AM; University of California San Diego, San Diego, CA, USA.
  • Chien AJ; University of California San Francisco, San Francisco, CA, USA.
  • Isaacs C; Georgetown University, Washington, DC, USA.
  • Boughey JC; Mayo Clinic, Rochester, MN, USA.
  • Albain KS; Loyola University, Chicago, IL, USA.
  • Kemmer K; Oregon Health & Science University, Portland, OR, USA.
  • Haley BB; University of Texas Southwestern, Dallas, TX, USA.
  • Han HS; Moffitt Cancer Center, Tampa, FL, USA.
  • Forero-Torres A; University of Alabama Birmingham, Birmingham, AL, USA.
  • Elias A; University of Colorado Denver, Aurora, CO, USA.
  • Lang JE; University of Southern California, Los Angeles, CA, USA.
  • Ellis ED; Swedish Cancer Institute, Seattle, WA, USA.
  • Yung R; University of Washington, Seattle, WA, USA.
  • Tripathy D; MD Anderson Cancer Center, Houston, TX, USA.
  • Nanda R; University of Chicago, Chicago, IL, USA.
  • Wulfkuhle JD; MD Anderson Cancer Center, Houston, TX, USA.
  • Brown-Swigart L; University of California San Francisco, San Francisco, CA, USA.
  • Gallagher RI; MD Anderson Cancer Center, Houston, TX, USA.
  • Helsten T; University of California San Diego, San Diego, CA, USA.
  • Roesch E; University of California San Diego, San Diego, CA, USA.
  • Ewing CA; University of California San Francisco, San Francisco, CA, USA.
  • Alvarado M; University of California San Francisco, San Francisco, CA, USA.
  • Crane EP; Georgetown University, Washington, DC, USA.
  • Buxton M; Berry Consultants, LLC, Houston, TX, USA.
  • Clennell JL; Berry Consultants, LLC, Houston, TX, USA.
  • Paoloni M; Berry Consultants, LLC, Houston, TX, USA.
  • Asare SM; University of California San Francisco, San Francisco, CA, USA.
  • Wilson A; University of California San Francisco, San Francisco, CA, USA.
  • Hirst GL; University of California San Francisco, San Francisco, CA, USA.
  • Singhrao R; University of California San Francisco, San Francisco, CA, USA.
  • Steeg K; University of California San Francisco, San Francisco, CA, USA.
  • Asare A; University of California San Francisco, San Francisco, CA, USA.
  • Matthews JB; University of California San Francisco, San Francisco, CA, USA.
  • Berry S; Berry Consultants, LLC, Houston, TX, USA.
  • Sanil A; Berry Consultants, LLC, Houston, TX, USA.
  • Melisko M; University of California San Francisco, San Francisco, CA, USA.
  • Perlmutter J; Gemini Group, Ann Arbor, MI, USA.
  • Rugo HS; University of California San Francisco, San Francisco, CA, USA.
  • Schwab RB; University of California San Diego, San Diego, CA, USA.
  • Symmans WF; MD Anderson Cancer Center, Houston, TX, USA.
  • Hylton NM; University of California San Francisco, San Francisco, CA, USA.
  • Berry DA; Berry Consultants, LLC, Houston, TX, USA.
  • Esserman LJ; University of California San Francisco, San Francisco, CA, USA.
Nat Commun ; 12(1): 6428, 2021 11 05.
Article en En | MEDLINE | ID: mdl-34741023
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante / Ado-Trastuzumab Emtansina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante / Ado-Trastuzumab Emtansina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article